Drug recall · May 23, 2018
Piperacillin and Tazobactam for Injection recall
Why: Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30
- Lots / codes
Lot #s: PP0317061-A, PP0317049-A; EXP August 2019
- Quantity
- 77,400 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA
- Initiated
- May 1, 2018 · Voluntary: Firm initiated
- Classified
- July 17, 2018
- Reported
- May 23, 2018
- Ended
- June 21, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Piperacillin / tazobactam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.